In a more recent study, Neubert et al. analyzed TFF3 levels in 89 who women underwent hysteroscopy and endometrial biopsy for postmenopausal bleeding [42–45], showing how TFF3 levels were significantly higher in patients with endometrial carcinoma compared with endometrial hyperplasia group [46]. The gene discussed is TFF3; the disease is endometrial carcinoma.